National HealthCare Corporation (NYSEAMERICAN:NHC – Get Free Report) shares reached a new 52-week high during trading on Friday . The stock traded as high as $206.12 and last traded at $202.7050, with a volume of 15037 shares. The stock had previously closed at $201.53.
Wall Street Analysts Forecast Growth
A number of equities research analysts have issued reports on the stock. The Goldman Sachs Group raised shares of National HealthCare to a “strong-buy” rating in a report on Monday, May 18th. Royal Bank Of Canada raised National HealthCare to a “hold” rating in a report on Monday, May 18th. Robert W. Baird upgraded National HealthCare to a “strong-buy” rating in a research report on Monday, May 18th. Finally, BMO Capital Markets upgraded National HealthCare to a “hold” rating in a research note on Monday, May 18th. Two analysts have rated the stock with a Strong Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Buy”.
National HealthCare Price Performance
National HealthCare (NYSEAMERICAN:NHC – Get Free Report) last released its quarterly earnings data on Thursday, May 7th. The company reported $1.91 EPS for the quarter. The company had revenue of $381.82 million during the quarter. National HealthCare had a net margin of 8.10% and a return on equity of 9.98%.
National HealthCare Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Tuesday, June 30th will be paid a $0.67 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $2.68 annualized dividend and a yield of 1.3%. This is a boost from National HealthCare’s previous quarterly dividend of $0.64. National HealthCare’s dividend payout ratio is currently 59.12%.
Insider Buying and Selling
In other news, Director Lisa Piercey purchased 949 shares of National HealthCare stock in a transaction dated Monday, June 1st. The stock was purchased at an average cost of $184.26 per share, for a total transaction of $174,862.74. Following the transaction, the director directly owned 949 shares of the company’s stock, valued at approximately $174,862.74. This trade represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink. 13.92% of the stock is currently owned by insiders.
Institutional Investors Weigh In On National HealthCare
A number of institutional investors and hedge funds have recently made changes to their positions in the business. Royal Bank of Canada boosted its stake in National HealthCare by 53.6% during the first quarter. Royal Bank of Canada now owns 2,724 shares of the company’s stock valued at $253,000 after buying an additional 950 shares during the period. AQR Capital Management LLC raised its holdings in shares of National HealthCare by 1.7% in the 1st quarter. AQR Capital Management LLC now owns 16,080 shares of the company’s stock valued at $1,492,000 after acquiring an additional 262 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of National HealthCare by 3.1% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,247 shares of the company’s stock valued at $858,000 after acquiring an additional 281 shares in the last quarter. Goldman Sachs Group Inc. boosted its position in shares of National HealthCare by 7.1% during the 1st quarter. Goldman Sachs Group Inc. now owns 73,772 shares of the company’s stock valued at $6,846,000 after acquiring an additional 4,879 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in shares of National HealthCare by 18.1% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 30,246 shares of the company’s stock valued at $2,807,000 after acquiring an additional 4,628 shares during the last quarter. Hedge funds and other institutional investors own 56.44% of the company’s stock.
National HealthCare Company Profile
National HealthCare Corporation (NYSE American: NHC) is a healthcare services company specializing in long-term care and post-acute rehabilitation. The company operates skilled nursing facilities, assisted living communities and outpatient therapy clinics. Through its subsidiary, National HealthCare Partners, NHC provides contract rehabilitation services, pharmacy management and clinical consulting to a broad network of senior living and healthcare providers.
Headquartered in Murfreesboro, Tennessee, National HealthCare Corporation has built a regional footprint across the southeastern and south-central United States.
Read More
- Five stocks we like better than National HealthCare
- Xcel Energy Stock Offers Stability as Electricity Demand Builds
- Data Center Delays Create Opportunity in These 3 Stocks
- Uncle Sam Plugs In: Nuclear Energy’s Cash Flow Moment Is Finally Here
- Fabrinet Is Becoming a Quiet Winner in the AI Optics Buildout
Receive News & Ratings for National HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png){kind=logo}
